Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Anthony Mccamish currently holds 22,000 shares of PDL BIOPHARMA, INC. (PDLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Anthony Mccamish has been a net seller of PDLI stock. They have purchased $985.1K and sold $6.3M worth of shares.
Mark Anthony Mccamish's most recent insider trade was on Jul 29, 2025, when they sold 11,000 shares at $0.00 per share.
Mark Anthony Mccamish serves as Executive at PDL BIOPHARMA, INC. (PDLI). They have executed 45 insider transactions totaling $7.3M over their tenure at the company.
Mark Anthony Mccamish holds the position of Executive at PDL BIOPHARMA, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Mark Anthony Mccamish has shown a selling trading pattern, with $985.1K in total purchases and $6.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark Anthony Mccamish was on Apr 1, 2020, when they sold $2.9M worth of FTSV shares. This transaction involved 30,237 shares at $95.42 per share.
Mark Anthony Mccamish currently owns 22,000 shares of PDL BIOPHARMA, INC. (PDLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Anthony Mccamish's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Anthony Mccamish has 45 Form 4 filings on record as an insider at PDL BIOPHARMA, INC..
Set alerts for Mark Anthony Mccamish and 40,000+ other insiders.